Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 03:06PM
|
Re: Short interest drops to 264,837
|
2
|
Resverlogix Corp.
|
May 07, 2020 12:15PM
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 28, 2020 10:42AM
|
Re: Option(s)?
|
2
|
Resverlogix Corp.
|
Sep 14, 2020 03:46PM
|
Re: Not much happening these days regarding share price
|
2
|
Resverlogix Corp.
|
Apr 10, 2019 08:36PM
|
Re: Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
|
2
|
Zenith Epigenetics
|
Jul 07, 2022 07:23AM
|
Re: I think one major reason that,
|
2
|
Resverlogix Corp.
|
Nov 01, 2019 03:50PM
|
Re: Thanks
|
2
|
Resverlogix Corp.
|
May 12, 2021 10:18AM
|
Re: I think one major reason that,
|
2
|
Resverlogix Corp.
|
Nov 01, 2019 03:54PM
|
Re: Setting expectations....
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 08:34AM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
2
|
Resverlogix Corp.
|
May 26, 2022 09:21AM
|
Re: a $6 sell order drops ZEN 96% !
|
2
|
Zenith Epigenetics
|
May 02, 2024 06:24AM
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 23, 2019 02:13PM
|
Extracorporeal membrane oxygenation
|
2
|
Resverlogix Corp.
|
Apr 01, 2021 09:23AM
|
Annual Financial Reporting
|
2
|
Resverlogix Corp.
|
Apr 02, 2024 08:00AM
|
Re: Update
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 11:59AM
|
Re: I'm glad dosing has begun... How long until results...
|
2
|
Resverlogix Corp.
|
Jan 19, 2022 04:02PM
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 07, 2019 06:47AM
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 06, 2019 02:31PM
|
SPP finally on the move
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2019 01:38PM
|